Hepatitis C is a liver virus that, if left untreated, can cause serious and life-threatening damage. At-risk groups include drug users, prisoners, homeless individuals, and those from regions where the virus is endemic. The NHS in England is working towards eliminating hepatitis C as a public health threat by expanding rapid testing and a medicines deal. The World Health Organization aims to eliminate the virus globally by 2030, with more than 60,000 people potentially living with hepatitis C in England unaware of their status.
The ongoing elimination programme has treated around 84,000 people for hepatitis C since 2015. The NHS is committed to securing antiviral medications and providing portable testing devices to reach at-risk populations. The goal is to encourage anyone who may have been exposed to the virus to get tested, as early diagnosis and treatment can prevent serious liver damage. The NHS is investing in accessible testing options, including screening programmes and self-administered tests at home. The focus is on accelerating testing, providing effective treatment options, reducing stigma, and preventing new infections, particularly among people who inject drugs.
The NHS emphasizes the importance of early detection and treatment of hepatitis C, as symptoms can go unnoticed for years and lead to severe health complications if left untreated. New portable testing devices and an extension of a commercial medicines deal are part of the initiative to reach those most at risk. The NHS encourages anyone who may have been exposed to the virus, even in the past, to get tested, especially if they have a history of drug use, medical treatment abroad, or unprotected sex with an infected person. The goal is to make testing quick, free, and accessible to prevent long-term health consequences.
The NHS’s 10-year elimination programme aims to position England as a leader in hepatitis C elimination efforts, with a focus on reaching vulnerable populations and increasing access to testing and treatment. By implementing rapid testing technologies and securing antiviral medications, the NHS hopes to meet the WHO’s target of reducing new chronic cases by 90% globally by 2030. With increased awareness, testing, and treatment, hepatitis C could be eliminated as a public health threat in England and potentially set an international standard for addressing the virus.
Eliminating hepatitis C as a public health threat requires a multi-faceted approach that includes expanded testing, accessible treatment, stigma reduction, and prevention efforts. The NHS’s investment in portable testing devices and antiviral medications is a crucial step towards achieving this goal. By encouraging at-risk individuals to get tested and providing necessary support for treatment, the NHS aims to save lives, reduce health disparities, and lead the way in the global fight against hepatitis C. With commitment and innovation, the elimination of hepatitis C in England is not only feasible but could serve as a model for other countries working towards the same goal.
